These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25597633)

  • 21. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity.
    Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura A; Lawrence J; Berstein L; Yue W
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S61-73. PubMed ID: 16113100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
    Han L; Liu B; Jiang L; Liu J; Han S
    Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-Abl regulates estrogen receptor alpha transcription activity through its stabilization by phosphorylation.
    He X; Zheng Z; Song T; Wei C; Ma H; Ma Q; Zhang Y; Xu Y; Shi W; Ye Q; Zhong H
    Oncogene; 2010 Apr; 29(15):2238-51. PubMed ID: 20101225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity.
    Thomas RS; Sarwar N; Phoenix F; Coombes RC; Ali S
    J Mol Endocrinol; 2008 Apr; 40(4):173-84. PubMed ID: 18372406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells.
    Herynk MH; Beyer AR; Cui Y; Weiss H; Anderson E; Green TP; Fuqua SA
    Mol Cancer Ther; 2006 Dec; 5(12):3023-31. PubMed ID: 17172405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear translocation of MRTFA in MCF7 breast cancer cells shifts ERα nuclear/genomic to extra-nuclear/non genomic actions.
    Jehanno C; Percevault F; Boujrad N; Le Goff P; Fontaine C; Arnal JF; Primig M; Pakdel F; Michel D; Métivier R; Flouriot G
    Mol Cell Endocrinol; 2021 Jun; 530():111282. PubMed ID: 33894309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Four-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cell.
    Zhang F; Feng F; Yang P; Li Z; You J; Xie W; Gao X; Yang J
    Int J Biochem Cell Biol; 2012 Feb; 44(2):320-6. PubMed ID: 22094188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
    Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
    Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway.
    Ounzain S; Bowen S; Patel C; Fujita R; Heads RJ; Budhram-Mahadeo VS
    Breast Cancer Res; 2011 Jan; 13(1):R5. PubMed ID: 21241485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.
    Fan P; Wang J; Santen RJ; Yue W
    Cancer Res; 2007 Feb; 67(3):1352-60. PubMed ID: 17283173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.
    Bhatt S; Stender JD; Joshi S; Wu G; Katzenellenbogen BS
    Oncogene; 2016 Nov; 35(44):5722-5734. PubMed ID: 27065334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression.
    Sarwar N; Kim JS; Jiang J; Peston D; Sinnett HD; Madden P; Gee JM; Nicholson RI; Lykkesfeldt AE; Shousha S; Coombes RC; Ali S
    Endocr Relat Cancer; 2006 Sep; 13(3):851-61. PubMed ID: 16954434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
    Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
    Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.
    Rajbhandari P; Ozers MS; Solodin NM; Warren CL; Alarid ET
    J Biol Chem; 2015 May; 290(22):13749-62. PubMed ID: 25866209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coactivator-mediated estrogen response in human squamous cell carcinoma lines.
    Ku TK; Crowe DL
    J Endocrinol; 2007 Apr; 193(1):147-55. PubMed ID: 17400812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
    Trauernicht AM; Kim SJ; Kim NH; Boyer TG
    Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel roles for ERK5 and cofilin as critical mediators linking ERα-driven transcription, actin reorganization, and invasiveness in breast cancer.
    Madak-Erdogan Z; Ventrella R; Petry L; Katzenellenbogen BS
    Mol Cancer Res; 2014 May; 12(5):714-27. PubMed ID: 24505128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
    Lin Z; Reierstad S; Huang CC; Bulun SE
    Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.